Generalized Pustular Psoriasis: Provider and Payer Considerations for Care
Adherence to Somatropin Therapy in the United States: Highlights of a Real-world Study of Patients With Pediatric Growth Hormone Deficiency
A Review of the Current Management and Burden of Prurigo Nodularis in the United States
Exploring Emerging Therapies in Pulmonary Arterial Hypertension
Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion
Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial
Striving Towards Cancer Health Equity Through Community Outreach: Highlights From a Cleveland Clinic Taussig Cancer Institute Symposium
This publication is supported by Seagen.
Treatment Landscape of ALK-positive Metastatic NSCLC: A Stakeholder Interchange Report
Addressing Unmet Needs in Chronic Phase CML With Third-Generation TKI
Payer and Provider Solutions to Utilization Management Challenges in the Management of Rare Hematologic Cancers
Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies
Volume: 29
Issue: 3
Understanding the Role of the Complement System in Rare Disease Therapeutics
Managed Care Considerations in the Management of CKD Associated With T2D
Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety
Evolving Considerations for Choice of Hepatitis B Vaccine
Medication Management Considerations in Chronic Obstructive Pulmonary Disease
Exclusive Coverage From the 64th American Society of Hematology Annual Meeting and Exposition
Coverage of the 64th American Society of Hematology Annual Meeting and Exposition, held December 10-13, 2022, in New Orleans, Louisiana
Disease Burden and Management of Vitiligo
Cost-Effectiveness Analysis of CAB-LA for PrEP in the United States
Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
Volume: 28
Issue: 16
The Evidence for Semaglutide 2.4 mg in Obesity From a Managed Care Perspective
Issue: 15
Optimizing Outcomes in Venous Thromboembolism Among Hospitalized Medically Ill Patients Through an Integrated Risk Assessment Program
Rethinking Heart Failure: Patient Classification and Treatment
Issue: 14
Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
Issue: 12
Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
Issue: 13
Digital Health Solutions in Chronic Illnesses: An AJMC® Scientific Interchange
Exclusive Coverage of the European Society for Medical Oncology Congress 2022
Coverage of the European Society for Medical Oncology Congress 2022, which took place in a virtual format and in person in Paris, France.
Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies
Issue: 9
Emerging Care Management Strategies for Severe Asthma: Integrating Biologic Therapy
Issue: 11
The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications
Issue: 8
